71
Views
7
CrossRef citations to date
0
Altmetric
Review

Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia

, MD, , BS, , PhD & , PhD
Pages 1367-1376 | Published online: 14 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lina Riedl, Ian R Mackenzie, Hans Förstl, Alexander Kurz & Janine Diehl-Schmid. (2014) Frontotemporal lobar degeneration: current perspectives. Neuropsychiatric Disease and Treatment 10, pages 297-310.
Read now

Articles from other publishers (6)

Rogier A. Feis, Mark J.R.J. Bouts, Jessica L. Panman, Lize C. Jiskoot, Elise G.P. Dopper, Tijn M. Schouten, Frank de Vos, Jeroen van der Grond, John C. van Swieten & Serge A.R.B. Rombouts. (2019) Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. NeuroImage: Clinical 22, pages 101718.
Crossref
Rogier A. Feis, Mark J.R.J. Bouts, Jessica L. Panman, Lize C. Jiskoot, Elise G.P. Dopper, Tijn M. Schouten, Frank de Vos, Jeroen van der Grond, John C. van Swieten & Serge A.R.B. Rombouts. (2018) Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. NeuroImage: Clinical 20, pages 188-196.
Crossref
Amanda R. MasonAdam ZiemannSteven Finkbeiner. (2014) Targeting the low-hanging fruit of neurodegeneration. Neurology 83:16, pages 1470-1473.
Crossref
Terry E. Goldberg & Jesus J. Gomar. (2013) Comment on ?Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012?. European Neuropsychopharmacology 23:8, pages 788-789.
Crossref
Masood Manoochehri & Edward D. Huey. (2012) Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia. Current Neurology and Neuroscience Reports 12:5, pages 528-536.
Crossref
Christopher D. Walentas, Diana W. Shineman, Antony R. Horton, Bradley F. Boeve & Howard M. Fillit. (2011) An analysis of global research funding for the frontotemporal dementias: 1998–2008. Alzheimer's & Dementia 7:2, pages 142-150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.